Article info

Download PDFPDF

Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study
  1. Correspondence to:
    Dr D E Furst
    Division of Rheumatology, Department of Medicine, University of California Los Angeles,32–59 Rehabilitation Center, 1000 Veteran Avenue, Los Angeles, CA 90095–1670, USA;DEFurst{at}mednet.ucla.edu
View Full Text

Citation

Furst DE, Gaylis N, Bray V, et al
Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study

Publication history

  • Accepted February 26, 2007
  • First published April 5, 2007.
Online issue publication 
June 18, 2007

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.